Infliximab use in Crohn's disease: impact on health care resources in the UK.
Jewell DP, Satsangi J, Lobo A, Probert C, Forbes A, Ghosh S, Shaffer J, Frenz M, Drummond H, Troy G, Turner S, Younge L, Evans L, Moosa M, Rodgers-Gray B, Buchan S.
Jewell DP, et al. Among authors: probert c.
Eur J Gastroenterol Hepatol. 2005 Oct;17(10):1047-52. doi: 10.1097/00042737-200510000-00007.
Eur J Gastroenterol Hepatol. 2005.
PMID: 16148549